112 related articles for article (PubMed ID: 10855460)
1. How common is violence in schizophrenia despite neuroleptic treatment?
Steinert T; Sippach T; Gebhardt RP
Pharmacopsychiatry; 2000 May; 33(3):98-102. PubMed ID: 10855460
[TBL] [Abstract][Full Text] [Related]
2. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
Bobes J; Fillat O; Arango C
Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
[TBL] [Abstract][Full Text] [Related]
3. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
Volavka J
J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
[TBL] [Abstract][Full Text] [Related]
4. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
[TBL] [Abstract][Full Text] [Related]
5. Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder.
Nolan KA; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome LL; McEvoy J; Lieberman JA
J Psychiatr Res; 2005 Jan; 39(1):109-15. PubMed ID: 15504429
[TBL] [Abstract][Full Text] [Related]
6. Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility.
Beck NC; Greenfield SR; Gotham H; Menditto AA; Stuve P; Hemme CA
J Am Acad Psychiatry Law; 1997; 25(4):461-8. PubMed ID: 9460034
[TBL] [Abstract][Full Text] [Related]
7. Predictors of violent behavior among acute psychiatric patients: clinical study.
Amore M; Menchetti M; Tonti C; Scarlatti F; Lundgren E; Esposito W; Berardi D
Psychiatry Clin Neurosci; 2008 Jun; 62(3):247-55. PubMed ID: 18588583
[TBL] [Abstract][Full Text] [Related]
8. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
Taylor D; Hayhurst K; Kerwin R
Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
[TBL] [Abstract][Full Text] [Related]
9. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
[TBL] [Abstract][Full Text] [Related]
11. [The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].
Klimke A; Klieser E
Fortschr Neurol Psychiatr; 1995 May; 63(5):173-93. PubMed ID: 7782019
[TBL] [Abstract][Full Text] [Related]
12. Incidents of violence in psychiatric inpatient care.
Omérov M; Edman G; Wistedt B
Nord J Psychiatry; 2002; 56(3):207-13. PubMed ID: 12079573
[TBL] [Abstract][Full Text] [Related]
13. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
14. [Long-term clinical experience with clozapine].
Gelly F; Chambon O; Marie-Cardine M
Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
[TBL] [Abstract][Full Text] [Related]
15. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
Chaichan W
J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
18. Inpatient violence and the schizophrenic patient: an inverse correlation between danger-related events and neuroleptic levels.
Yesavage JA
Biol Psychiatry; 1982 Nov; 17(11):1331-7. PubMed ID: 7150681
[TBL] [Abstract][Full Text] [Related]
19. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.
McElroy SL; Dessain EC; Pope HG; Cole JO; Keck PE; Frankenberg FR; Aizley HG; O'Brien S
J Clin Psychiatry; 1991 Oct; 52(10):411-4. PubMed ID: 1938976
[TBL] [Abstract][Full Text] [Related]
20. [Are coercive measures carried out arbitrarily?].
Steinert T; Gebhardt RP
Psychiatr Prax; 2000 Sep; 27(6):282-5. PubMed ID: 11050734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
